Plain-words guide

HER2 test meaning: positive, negative and HER2-low explained

What a HER2 test measures, what positive, negative and HER2-low results can mean in breast cancer, and what to ask your oncologist about your report.

What is HER2?

HER2 stands for human epidermal growth factor receptor 2. It is a protein found on the surface of some cells, and it helps cells grow and divide. The HER2 test checks how much of this protein, or how many copies of its gene, a tumour sample carries.

HER2 testing is most often done for breast cancer, but it is also done for some other cancers, such as certain stomach and gastro-oesophageal cancers. Knowing the result helps the oncologist understand the cancer better and discuss treatment options. On its own, though, it is one detail in a larger picture that also includes the cancer type, stage and other tests.

How the HER2 test is done: IHC and FISH

The test is usually done on tissue taken during a biopsy or surgery, and it is read by a pathologist, the doctor who studies tissue under a microscope. Two laboratory methods are used.

Often IHC is done first. If the IHC score is clear, the result may be reported as it is. If the score falls in an in-between group, the lab may run FISH on the same sample for a clearer answer. Reports use different wording, such as scores written with a plus sign, so the same result can look different from one lab to another. Ask which method was used for yours.

  • IHC, immunohistochemistry: a stain shows how much HER2 protein is on the cells
  • FISH, fluorescence in situ hybridisation: counts copies of the HER2 gene

What a HER2-positive result can mean

A HER2-positive result usually means the tumour sample has more HER2 protein, or more copies of the HER2 gene, than usual. It describes a feature of the tumour. It does not say how serious the cancer is, and it is not a good or bad sign by itself.

HER2-positive cancers can behave differently from HER2-negative ones, and medicines aimed at HER2 exist. Whether any such medicine is discussed for a particular person depends on the cancer type, its stage, other test results and overall health, so only the oncologist can say. Ask which test gave the result, whether it needs to be confirmed, and how it fits with the rest of your reports.

What a HER2-negative result can mean

A HER2-negative result usually means the tumour sample does not have extra HER2 protein or extra copies of the HER2 gene. Like a positive result, it describes the tumour; it is not a judgement on how the cancer will behave.

HER2-negative breast cancers are still treated, and many treatment options exist. Which ones are discussed depends on other details in the report, such as hormone receptor results, the stage, the grade and the person's general health. Sometimes a result falls in a borderline or unclear group, and another test may be suggested. Ask your oncologist to go through the HER2 line with you and explain what it changes, and what it does not.

What HER2-low means

HER2-low is a newer way of describing tumours that have a small amount of HER2 protein, but not enough to be called HER2-positive. In older reports, these tumours are usually grouped under HER2-negative, which is why the term can feel confusing.

HER2-low is not a separate type of cancer. It describes a test result, usually from the IHC method, where the lab gives a score based on how strongly the cells stain. Doctors have begun to pay attention to this group because research is still looking at whether some medicines may help people whose tumours show a little HER2. Whether it matters for you depends on the cancer type and the rest of the report.

Questions to ask your oncologist

Carry a copy of the full report to every visit, so the doctor can see the exact wording and the method used. A cancer is not always the same all through, so results from a biopsy and a later surgery sample, or from two labs, can sometimes differ. If you have more than one HER2 result, keep all the reports together and show them.

Write your questions down before the visit. Your oncologist explains what your result means for you.

  • Which test gave this result, IHC or FISH?
  • Does the result need to be confirmed or repeated?
  • Does HER2-low or a low score affect the options being discussed?
  • If I have two results, which one do you rely on?
  • How does this fit with the rest of my reports?

Find HER2 in your report with OncoVOIS

HER2 usually appears in the pathology or biopsy report, often in a section on biomarkers, receptor status or special tests. It may be written as HER2, HER2/neu, ERBB2, or as an IHC score or FISH result. Lab reports vary, so it can be hard to spot.

With OncoVOIS, you add a report with your camera, a photo, a PDF or a Word file. The app reads it and shows what it found, and you check it before anything is saved. The summary explains hard words in plain language, and the Cancer profile gathers details such as markers in one place, showing which report each came from. The app does not tell you what a result means for you; take that question to your oncologist.

Frequently asked questions

What is the HER2 test, and what is the full form of HER2?

HER2 stands for human epidermal growth factor receptor 2. It is a protein found on the surface of some cells, and it helps cells grow and divide. The HER2 test checks how much of this protein, or how many copies of its gene, a tumour sample carries.

The test is usually done on a piece of tissue taken during a biopsy or surgery, and it is read by a pathologist, the doctor who studies tissue under a microscope. Some cancers have more HER2 than others, and knowing this helps the oncologist understand the cancer better and discuss treatment options. A HER2 result on its own is only one detail in a larger picture that also includes the cancer type, stage and other tests. Your oncologist can explain what the result means in your own case, and which other results to read alongside it.

What does a HER2 test positive result mean?

A HER2-positive result usually means the tumour sample has more HER2 protein, or more copies of the HER2 gene, than usual. It describes a feature of the tumour. It does not say how serious the cancer is, and it is not a good or bad sign by itself.

HER2-positive cancers can behave differently from HER2-negative ones, and medicines that are aimed at HER2 exist. Whether any such medicine is discussed for a particular person depends on the cancer type, its stage, other test results and overall health, so only the oncologist can say. If your report says positive, ask your oncologist which test gave that result, whether it needs to be confirmed, and how it fits with the rest of your reports. It helps to carry a copy of the full report to every visit, so the doctor can see the exact wording and the method used.

What does HER2 test negative mean in breast cancer?

A HER2-negative result usually means the tumour sample does not have extra HER2 protein or extra copies of the HER2 gene. This is a description of the tumour, not a judgement on how the cancer will behave.

HER2-negative breast cancers are still treated, and many treatment options exist. Which ones are discussed depends on other details in the report, such as hormone receptor results, the stage, the grade and the person's general health. A report may also place a result in a borderline or unclear group, and then another test may be suggested. Some reports in this group show a small amount of HER2, which is where the term HER2-low comes from. If you are unsure what your report means, ask your oncologist to go through the HER2 line with you and explain what it changes, and what it does not change.

What does HER2-low mean on a breast cancer report?

HER2-low is a newer way of describing tumours that have a small amount of HER2 protein, but not enough to be called HER2-positive. These tumours are usually grouped under HER2-negative in older reports, which is why the term can feel confusing.

HER2-low is not a separate type of cancer. It describes a result from the test, usually the IHC method, where the lab gives a score based on how strongly the cells stain. Doctors have begun to pay attention to this group because research is still looking at whether some medicines may help people whose tumours show a little HER2. Whether it matters for a particular person depends on the cancer type and the rest of the report. If your report mentions HER2-low or a low score, ask your oncologist what it means for you and whether it affects the options being discussed.

What is the difference between IHC and FISH in a HER2 test?

IHC and FISH are two lab methods used to check HER2. IHC, short for immunohistochemistry, uses a special stain to show how much HER2 protein is on the cells, and the result is given as a score. FISH, short for fluorescence in situ hybridisation, counts the copies of the HER2 gene inside the cells.

Often IHC is done first. If the IHC score is clear, the result may be reported as it is. If the score falls in an in-between group, the lab may run FISH on the same sample to get a clearer answer. Reports can use different wording, such as scores written with a plus sign, so the same result can look different from one lab to another. Ask your oncologist or the lab to explain which method was used and what each line of your report means.

Is the HER2 test only done for breast cancer?

No. HER2 testing is most often done for breast cancer, but it is also done for some other cancers, such as certain stomach and gastro-oesophageal cancers, and it may be used in a few other types as well. Which cancers are tested varies, and guidelines change over time.

So if you see HER2 on a report for a cancer other than breast cancer, that is not unusual. The way the result is scored and read can differ from one cancer type to another, which is why the same word, positive or negative, should always be read together with the cancer type named in the report. Not every person with these cancers needs the test, and the decision to order it rests with the treating doctor. If you are not sure whether HER2 testing applies to your cancer, ask your oncologist whether it has been done or is planned.

Can a HER2 result change, or differ between two tests?

Sometimes, yes. A cancer is not always the same all through, so a result from a biopsy and a result from a later surgery sample, or from a second site of cancer, can sometimes be different. A result can also differ between labs because the methods need careful handling and reading.

When a result is unclear, unexpected or does not fit the rest of the picture, the oncologist may ask for the test to be repeated or for the slides to be looked at again. This does not always mean something has gone wrong. It is a normal part of making sure the information is as reliable as it can be. If you have more than one HER2 result with different wording, keep all the reports together and show them to your oncologist. Useful questions are: which result do you rely on, and does a repeat test make sense for me?

How can I find the HER2 result in my own reports?

Look in the pathology or biopsy report, usually in a section on biomarkers, receptor status or special tests. HER2 may appear as HER2, HER2/neu, ERBB2, or as an IHC score or a FISH result. Lab reports vary, so it can be hard to spot.

With OncoVOIS, you can add a report with your camera, a photo, a PDF or a Word file. The app reads it and shows what it found, and you check it before anything is saved. The report summary explains hard words in plain language, and the Cancer profile gathers details such as markers in one place, showing which report each detail came from. You can also type or speak a question in Ask. The app says when it is not sure and may ask you to confirm details. It does not tell you what a result means for you, so take the questions to your oncologist.

This page is general information, not medical advice. OncoVOIS explains and helps you prepare; your oncologist decides about your care.